Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Advisory Panel To Evaluate Acetaminophen Pediatric Dosing

This article was originally published in The Tan Sheet

Executive Summary

FDA's pediatric and nonprescription drugs advisory committees will consider whether the agency should add dosing information for children under 2 years to labels for OTC products containing acetaminophen at a joint meeting May 17-18.
Advertisement

Related Content

Acetaminophen Panel To Mull Expanded Dosing, Standard Solid Concentration
Acetaminophen Panel To Mull Expanded Dosing, Standard Solid Concentration
Acetaminophen Panel To Mull Expanded Dosing, Standard Solid Concentration
Lower Acetaminophen Doses Recommended Despite Cost Impact, Lack Of Data
Pediatric Acetaminophen Expanded Dosing Requested In McNeil Petition
Pediatric Acetaminophen Expanded Dosing Requested In McNeil Petition
OTC pediatric analgesic directions for infant dosing recommended by NDAC.

Topics

Advertisement
UsernamePublicRestriction

Register

PS104915

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel